Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Eskelund, Christian Winther, Albertsson-Lindblad, Alexandra, Kolstad, Arne, Laurell, Anna, Räty, Riikka, Pedersen, Lone Bredo, Geisler, Christian Hartmann, Jerkeman, Mats, Grønbæk, Kirsten
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2018
Matèries:
Online Only Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6278958/
https://ncbi.nlm.nih.gov/pubmed/29794145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.194399
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars